Avanos Medical, Inc.
AVNSHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Avanos Medical, Inc. focuses on Medical Devices services and products. Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company carries a $1.16B market cap, placing it firmly in the small-cap category. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Market Cap
$1.16B
Beta
1.59
P/E (TTM)
—
P/E (Fwd)
19.81
EPS (TTM)
$-1.60
EPS (Fwd)
$1.25
ROE
-9.2%
ROA
0.9%
Cash
$65.6M
Total Debt
$138.4M
Free CF
$17.1M
52W Change
97.0%
Annual Financials
Cash vs Debt
Avanos Medical, Inc. carries $138.4M in total debt against $65.6M in cash reserves — debt is roughly 2.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $17.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -9.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 0.9% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $587.0M to $701.2M.
With a beta above 1.5, AVNS tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AVNS.